Bevacizumab in Combination With Different Platinum-Based Doublets in the First-Line Treatment for Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
International Journal of Cancer - United States
doi 10.1002/ijc.31175
Full Text
Open PDFAbstract
Available in full text
Date
December 4, 2017
Authors
Publisher
Wiley